Genecast Biotechnology is a leading oncology molecular diagnostics and testing company in China, provides precision diagnostics products and services to assist patients to make decisions in cancer therapy selection, evaluate or improve treatment options and provide cancer early screening for high-risk populations. It is dedicated to serve as the most professional and trusted partner for hospitals and patients, and is one of the few oncology molecular diagnostics and testing companies in China to provide one-stop solutions to hospitals.
2022.01
Genomeweb | Genecast Minimal Residual Disease Test Plans Bolstered by New Lung Cancer Data
2019.10
Genecast Biotechnology Receives ¥300 Million in Series D1 Financing
2019.09
Genecast Biotechnology Wins “EY Fudan China the Most Promising Enterprises Award”
2019.09
Genecast Biotechnology Obtains Qualification for NGS Detection
Genecast was established in Beijing in 2014 and is headquartered in the city of Wuxi, Jiangsu Province. With the next-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients. With the next-generation sequencing technology and bioinformatics as the core, the company is engaged in non-invasive and precise diagnosis and diagnosis of tumors, and is committed to becoming a leader in improving the quality of life of cancer patients.
We are committed to being improved
the leader in the quality of life of cancer patients.